Last Updated : August 28, 2018
Details
FilesProject Status:
Completed
Project Line:
Health Technology Review
Project Sub Line:
Summary with Critical Appraisal
Project Number:
RC1005-000
Question
- What is the clinical effectiveness of higher or more frequent versus standard dosing of biologics for the treatment of inflammatory bowel disease?
- What is the clinical effectiveness of higher or more frequent than standard dosing versus switching biologics for the treatment of inflammatory bowel disease?
- What is the cost-effectiveness of higher or more frequent versus standard dosing of biologics for the treatment of inflammatory bowel disease?
- What is the cost-effectiveness of higher or more frequent than standard dosing versus switching of biologics for the treatment of inflammatory bowel disease?
- What are the evidence-based guidelines regarding higher or more frequent than standard dosing of biologics for the treatment of inflammatory bowel disease?
Files
Last Updated : August 28, 2018